"I have to admit that in all 39 years of my career as a community pharmacist, I have never seen a drug that was the center of such intense political discussion."

Opinion: Hydroxychloroquine at the Center of COVID-19 Discussions

New digital health products are providing more insight into data and the opportunity for real-time patient interaction.

Technology Innovations Transforming Pharmacy Practice

Heart disease is so common among Americans that it claims 1 life every 37 seconds.

The Pharmacist's Role in Heart Health

Pharmacists are often the most accessible health care professionals, which is why a lack of access to pharmacies can have a detrimental effect on patients, especially those with chronic conditions. 

Pharmacy Schools Prepare Students for Specific Population Challenges

Thank you to pharmacy staff on the front lines. 

Social Media and COVID-19

Fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo) is indicated for treating adults with unresectable or metastatic HER2-positive breast cancer who have received 2 or more prior anti-HER2–based regimens in the setting of metastasis.

Fam-trastuzumab Deruxtecan-nxki for HER2-Positive Unresectable or Metastatic Breast Cancer

The current pandemic could lead to heightened demand for retail pharmacists and pharmacy technicians. 

Pharmacy Job Demand Could Grow Because of COVID-19

Investigators are evaluating a variety of medications for the novel coronavirus disease 2019 (COVID- 19), and the possible treatment landscape is rapidly evolving.

Investigational Drugs in the Pipeline for COVID-19

In the face of COVID-19, pharmacists continue to provide accessible care to patients.

Arm Yourself With Information During the COVID-19 Pandemic

Never before have so many brilliant minds, machines, and groups come together so quickly in an attempt to develop a vaccine.

A Flurry of COVID-19 Studies Are Underway, but Scientists Warn a Vaccine Will Take Time

If health care were a country, it would be the fifth largest emitter of greenhouse gases worldwide.

The Carbon Footprint in the Room: ‘Going Green’ in the Pharmacy

Insulin manufacturers are expanding insulin affordability options for patients with diabetes during the coronavirus pandemic. 

Insulin Affordability Options Expand During COVID-19

In a video interview with Drug Topics®, Robert Brunault, PharmD, a clinical pharmacy specialist of hematology and oncology at Rhode Island Hospital and Lifespan Cancer Institute, answers questions about how the COVID-19 pandemic affects patients undergoing treatment for cancer.

A Conversation About Cancer Care During COVID-19

Pharmacies, just as expected, have showed up in meaningful ways to support their communities.

Communicating with Patients in the Time of COVID-19

Officials with the FDA have requested that manufacturers of all ranitidine (Zantac) drugs, both prescription and over-the-counter, remove their products from the market. 

FDA Requests Removal of All Ranitidine from Market 

What the law says about pharmacists’ role in the opioid crisis-and how to protect yourself.

Drug Topics May 2020